GlassScriptPhysician profile
Anthony John Massimillo
NPI 1043277692
$1,711.20
in general payments reported to CMS, 2019-2025
16 companies · $124 in 2025
The $124 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $709 · 2020: $694 · 2021: $157 · 2022: $12.72 · 2024: $13.76 · 2025: $124.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $138.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $138.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $524.91 | 2019-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $250.17 | 2019-2021 | |
| Janssen Biotech, INC. | $162.68 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $129.39 | 2019-2020 | |
| Nestle Healthcare Nutrition INC. | $119.29 | 2020-2021 | |
| Qol Medical, LLC | $112.46 | 2019-2021 | |
| Ferring Pharmaceuticals INC. | $76.14 | 2019-2020 | |
| Ironwood Pharmaceuticals, INC | $58.58 | 2019-2020 | |
| Concordia Pharmaceuticals INC. | $55.10 | 2019 | |
| Pfizer INC. | $52.02 | 2019-2020 | |
| Redhill Biopharma INC. | $48.80 | 2020 | |
| Intercept Pharmaceuticals, INC. | $42.64 | 2020 | |
| Allergan, INC. | $36.82 | 2019-2020 | |
| Alfasigma USA, INC. | $15.72 | 2020 | |
| Pentax of America, INC. | $13.76 | 2024 | Pentax Medical, Inspira, C2 Cryoballoon Focal Controller |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $12.72 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Massimillo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.